Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases

 

The purpose of this program is to strengthen capacity to prevent disease, disability, and death through immunization and control of respiratory and related diseases. The specific objectives may include, but are not limited to: 1. Increase the population of children and adults who are free from respiratory infectious disease complications. 2. Strengthen local, state, and national capacity for the early detection, investigation, response and control of respiratory infections in order to accelerate early recognition of respiratory threats and to mitigate the impact of their spread. 3. Control the rise in antimicrobial resistant respiratory infections in the community. 4. Strengthen prevention and control of respiratory infections in institutional settings, such as health care facilities and workplaces. 5. Reduce mortality from pneumonia and other severe respiratory infections. 6. Strengthen capacity for early detection, investigation, response, and control of respiratory infectious threats.

Active 93.083 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Sec 317A, 317B, & 317(k) (2) PHS Act CFDA: 93.322; Public Health Service Act, Sections 301(a) [42 U.S.C. 241(a)] and 307 [42 U.S.C. 242l]; Authority and Regulations number is Section 307 of the Public Health Service Act (42 U.S.C. 242l); Section 307 of the Public Health Service Act, as amended (42 U.S.C. § 242l); Section 301(a) of the Public Health Service Act, as amended (42 U.S.C. § 241(a)); Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75.
Public Law - Dependent on the NOFO, eligibility may range from open competition, limited competition, single-source, domestic and/or international in accordance with the authorizing language. Not applicable. Applications should be submitted in compliance with instructions provided with each individual Notice of Funding Opportunity (NOFO). Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Refer to the individual NOFO for the administrative requirements and application procedures. Procedures are specified in the individual NOFOs. Contact the headquarters or regional location, as appropriate for application deadlines More than 180 days. As specified in the individual NOFO. Not applicable. Awards under this Program are typically issued for 1- to 5-year project periods. Renewals at the end of each project period are expected to be made available via the publication of a new/continuation NOFO with a complete application and review/award process as described in the NOFO. Annual renewals within an awarded multi-year project period are made via a non-competitive process and are subject to the availability of funds. Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC. Funds may be used towards prevention and control of disease, disability, and/or death through immunization against respiratory and related diseases. Restrictions to funding are designated in the individual Notice of Funding Opportunity (NOFO) and, for those awarded, in the Notice of Award (NoA). Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Yarnell Martin
1600 Clifton Road
Atlanta, GA 30329 US
hjz0@cdc.gov
Phone: 404-718-8842

Tiffany Jacobs
1600 Clifton Road
Atlanta, GA 30329 USA
tlw4@cdc.gov
Phone: 4047181111 75-0943-0-1-550 (Cooperative Agreements) FY 22$18,087,115.00; FY 23 est $18,087,115.00; FY 24 est $18,087,115.00; FY 21$26,528,918.00; - $500,000 - $2,000,000, Average $1,000,000 Not applicable. Not applicable.